If you are a UK Healthcare Professional, please visit Ferinject® for UK Healthcare Professional.

Skip to main content

Adverse Events

Reporting Adverse events in the UK:

This medicinal product is subject to additional monitoring.

This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via: United Kingdom, Yellow Card Scheme,

Website: www.mhra.gov.uk/yellowcard

or search for MHRA Yellow Card in the Google Play or Apple App Store

Adverse events should also be reported to Vifor Pharma UK Ltd. Tel: +44 1276 853633 or Email: medicalinfo_UK@viforpharma.com

 

Reporting side effects in Ireland:

Reporting side effects after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any side effects.

HPRA Pharmacovigilance

Earlsfort Terrace

IRL - Dublin 2

Tel: +353 1 6764971

Fax: +353 1 6762517

Website: www.hpra.ie

e-mail: medsafety@hpra.ie

 

Side effects should also be reported to Vifor Pharma UK Ltd. Tel: +44 1276 853633 or Email: medicalinfo_UK@viforpharma.com.

Home

Welcome to Ferinject.co.uk

This website is intended for healthcare professionals who treat iron deficiency and iron deficiency anaemia in adults or patients who have been prescribed this medication.

UK-FCM-1900320, September 2019